Headline: Ozempic Launched in India as Novo Targets Expanding Diabetes Market
Caption:
Novo Nordisk launched Ozempic in India, pricing the lowest 0.25 mg dose at about $24 a week as it moved to tap into the country's fast-growing diabetes and obesity market.
Keywords: Health & Wellbeing,Ozempic India,Novo Nordisk,semaglutide,diabetes treatment,obesity drugs,Indian pharma market,Wegovy,Mounjaro.